中国医药导报
中国医药期刊欢迎您 今天是   2025年4月16日星期三
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  调查研究 本期目录 | 过刊浏览 | 高级检索 |
我院呼吸科铜绿假单胞菌耐药性变迁及抗菌药物合理性分析
武阿龙      黄健      徐丙发
安徽医科大学第三附属医院药学部,安徽合肥   230061
Changes of drug resistance of Pseudomonas aeruginosa and rationality analysis of antibiotics in respiratory department of our hospital
WU Along   HUANG Jian   XU Bingfa
Department of Pharmacy, the Third Hospital Affiliated to Anhui Medical University, Anhui Province, Hefei   230061, China
全文: PDF (1268 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 调查呼吸科铜绿假单胞菌(PA)耐药性及患者抗菌药物选择,为合理使用抗菌药物提供依据。 方法 回顾性分析2013—2020年安徽医科大学第三附属医院(以下简称“我院”)铜绿假单胞菌耐药性变化趋势、呼吸科PA感染患者抗菌药物耐药率。根据药敏结果将纳入患者分为耐碳青霉烯类铜绿假单胞菌(CRPA)组(31例)和非耐碳青霉烯类铜绿假单胞菌(NCRPA)组(127例),评价两组抗菌药物选择合理性及转归情况。 结果 呼吸科PA对头孢他啶、头孢吡肟、哌拉西林他唑巴坦、亚胺培南的耐药性表现为先下降后上升的趋势,耐药率较全院水平稍高。CRPA组死亡率高于NCRPA组,抗菌药物选择的合理率低于NCRPA组,差异有统计学意义(P < 0.05)。不合理情况分别表现为未根据药敏结果联合使用抗菌药物、未选择PA敏感的抗菌药物。 结论 2015年后PA耐药率有逐年升高的趋势,关注具有耐药高危因素的患者,结合药敏结果选择抗菌药物对PA治疗具有临床指导作用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
武阿龙 黄健 徐丙发
关键词 铜绿假单胞菌耐药性耐碳青霉烯类铜绿假单胞菌抗菌药物    
Abstract:Objective To investigate the drug resistance of Pseudomonas aeruginosa (PA) in respiratory department and the choice of antibiotics in patients to provide evidence for rational use of antibiotics. Methods The trend of drug resistance of PA in the Third Affiliated Hospital of Anhui Medical University (hereinafter referred to as “our hospital”) from 2013 to 2020 was retrospectively analyzed, and the antimicrobial resistance rate of patients with PA infection in respiratory department was retrospectively analyzed. According to the drug susceptibility results, the included patients were divided into carbapenem-resistant pseudomonas aeruginosa (CRPA) group (31 cases) and non-carbapenem-resistant pseudomonas aeruginosa (NCRPA) group (127 cases). The rationality and outcome of the choice of antibiotics in the two groups were evaluated. Results The drug resistance of PA to ceftazidime, cefepime, piperacillin-tazobactam, and imipenem were showed a trend of first decline and then increased, and the drug resistance rate was slightly higher than that of the whole hospital. The mortality rate in the CRPA group was higher than that in the NCRPA group, while the rational rate of antibiotic selection was lower than that in the NCRPA group, with statistically significant differences (P < 0.05). The unreasonable situations were that the combination of antibiotics was not used according to the drug susceptibility results, and the PA-sensitive antibiotics were not selected. Conclusion After 2015, the PA drug resistance rate has been increasing year by year. Paying attention to patients with high risk factors of drug resistance and selecting antimicrobial drugs based on drug susceptibility results can guide the treatment of PA.
Key wordsPseudomonas aeruginosa    Resistance    Carbapenem-resistant pseudomonas aeruginosa    Antimicrobial drugs
    
基金资助:安徽省医疗卫生重点专科建设项目(皖卫函〔2021〕273号);
安徽省合肥市卫生计生应用医学研究项目(hwk20 16yb004)。
通讯作者: 徐丙发(1978.5-),男,博士,副主任药师,硕士生导师;研究方向:临床药学。   
作者简介: 武阿龙(1995.12-),男,硕士;研究方向:临床药学。
引用本文:   
武阿龙 黄健 徐丙发. 我院呼吸科铜绿假单胞菌耐药性变迁及抗菌药物合理性分析[J]. 中国医药导报, 2022, 19(17): 55-58,62.
WU Along HUANG Jian XU Bingfa. Changes of drug resistance of Pseudomonas aeruginosa and rationality analysis of antibiotics in respiratory department of our hospital. 中国医药导报, 2022, 19(17): 55-58,62.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/     或     https://www.yiyaodaobao.com.cn/CN/Y2022/V19/I17/55

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司